Bio-TechneTECH +19.35%83 Dividend Yield % is 0.45% as of Jun. 25, 2026, which is 15% below its 10-year median of 0.53. GuruFocus rates TECH with a GF Score™ of 83/100 and a GF Value™ of $72.49 (Fairly Valued). The stock has 4 warning signs investors should review. Among 151 Biotechnology companies, Bio-Techne ranks worse than 79.47% on this metric.
As of today (2026-06-25), the Trailing Annual Dividend Yield of Bio-Techne is 0.45%.
The historical rank and industry rank for Bio-Techne's Dividend Yield % or its related term are showing as below:
TECH'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.24 Med: 0.53 Max: 1.31
Current: 0.45
During the past 13 years, the highest Dividend Yield of Bio-Techne was 1.31%. The lowest was 0.24%. And the median was 0.53%.
TECH's Dividend Yield % is ranked worse than 79.47% of 151
companies
in the Biotechnology industry
Industry Median: 1.5
vs TECH: 0.45
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Bio-Techne was 13.90% per year. The lowest was 0.00% per year. And the median was 0.10% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
The historical data trend for Bio-Techne's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TECH vs HALO, IBRX, NUVL: Dividend Yield % Comparison
For the Biotechnology subindustry, Bio-Techne's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bio-Techne Dividend Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Bio-Techne's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Bio-Techne's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Bio-Techne Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
USD 0.080000
2026-05-18
2026-05-18
2026-05-29
Cash Dividend
quarterly
USD:USD 1.000000
USD 0.080000
2026-02-13
2026-02-16
2026-02-27
Cash Dividend
quarterly
USD:USD 1.000000
USD 0.080000
2025-11-17
2025-11-17
2025-11-28
Cash Dividend
quarterly
USD:USD 1.000000
USD 0.080000
2025-08-18
2025-08-18
2025-08-29
Cash Dividend
quarterly
USD:USD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Bio-Techne's Trailing Annual Dividend Yield (%) for Today is calculated as
Trailing Annual Dividend Yield
=
Most Recent Full Year Dividend
/
Current Share Price
=
0.32
/
70.2699
=
0.46 %
Current Share Price is $70.2699. Bio-Techne's Dividends per Share for the trailing twelve months (TTM) ended in Today is $0.32.
Bio-Techne's Forward Annual Dividend Yield (%) for Today is calculated as
Forward Annual Dividend Yield
=
Forward Full Year Dividend
/
Current Share Price
=
0.32
/
70.2699
=
0.46 %
Current Share Price is $70.2699. Bio-Techne's Dividends per Share for the forward twelve months is calculated as $0.08 * 4 = $0.32.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bio-Techne (TECH) has a Dividend Yield % of 0.45% as of Jun. 25, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Bio-Techne and its competitors. This is 15% below median its historical median of 0.53. Over the past decade, Bio-Techne's Dividend Yield % has ranged from 0.24 to 1.31. According to the industry distribution chart, Bio-Techne ranks #120 out of 151 companies in the Biotechnology industry, placing it in the top 79.5%.
Is Bio-Techne's Dividend Yield % too high?
Bio-Techne's current Dividend Yield % of 0.45% is 15% below median its 10-year median of 0.53. Over the past 10 years, this metric has ranged from a low of 0.24 to a high of 1.31. The Biotechnology industry median Dividend Yield % is 1.50. Bio-Techne's value of 0.45% is 70% below this industry median. Based on the distribution chart, Bio-Techne ranks #120 out of 151 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Bio-Techne has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bio-Techne's Dividend Yield % compare to HALO and IBRX?
According to the Biotechnology industry distribution chart, Bio-Techne ranks #120 out of 151 companies for Dividend Yield %. This places Bio-Techne in the lower half of its industry. The industry median Dividend Yield % is 1.50. Bio-Techne's value of 0.45% is 70% below this benchmark. Historically, Bio-Techne's own Dividend Yield % has ranged from 0.24 to 1.31 over the past decade. While the company's 10-year median is 0.53 vs. the industry median of 1.50, Bio-Techne has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Biotechnology company?
The median Dividend Yield % among Biotechnology companies is 1.50, based on 151 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bio-Techne's current Dividend Yield % of 0.45% is 70% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Bio-Techne and its competitors. For the Biotechnology industry, the median Dividend Yield % is 1.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bio-Techne's current Dividend Yield % is 0.45%, which is 15% below median its own 10-year median of 0.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Techne stock overvalued right now?
Based on GuruFocus' analysis, Bio-Techne (TECH) is currently considered Fairly Valued. The stock's GF Value™ is $72.49, compared to a current price of $70.27 — trading 3.1% below its estimated fair value. The current Dividend Yield % is 0.45%, which is 15% below median its 10-year median of 0.53 and 70% below the Biotechnology industry median of 1.50. Bio-Techne's overall GF Score™ is 83/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Bio-Techne (TECH), the current Dividend Yield % is 0.45% as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bio-Techne (TECH) Overvalued in 2026?
Based on GuruFocus' analysis, Bio-Techne stock appears to be undervalued.
The current stock price of $70.27 is trading 3.1% below its estimated GF Value™ of $72.49.
GuruFocus considers Bio-Techne to be Fairly Valued.
Key valuation signals for TECH:
Dividend Yield %: 0.45% (15% below median its 10-year median of 0.53)
GF Value™: $72.49 vs. price of $70.27 (3.1% below fair value)
Industry Position: 70% below the Biotechnology median (#120 of 151)
No single metric tells the full story. See the TECH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
83GF Score
Get the complete analysis for TECH
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TECH has been successfully added to your 
